Biologic Injectors Market Growth Report 2021 to 2031
The Biologic Injectors Market is expected to register a CAGR of 10.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Application (Oncology, Cardiology, Autoimmune, Pain management, Others). The report further presents analysis based on the End-User (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Other). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Biologic Injectors Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Biologic Injectors Market Segmentation
Application- Oncology
- Cardiology
- Autoimmune
- Pain management
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Other
Strategic Insights
Biologic Injectors Market Growth Drivers- Increasing Incidence of Chronic Diseases: The increasing incidence of chronic diseases, such as diabetes, rheumatoid arthritis, and cancer, is raising demand for biologic injectors. They allow the accurate and efficient administration of biologic drugs, thereby significantly enhancing patient compliance with treatment and minimizing the requirement for repeated hospitalization, increasing their acceptance across the world.
- Advances in Biologic Drugs: The rise of biologic drug therapies-from monoclonal antibodies to gene therapies-boost the demand for a practical drug delivery system. Biologic injectors are essential for administering these complex, expensive drugs; self-administering will save healthcare resources, not to mention giving patients the security of getting precise and predictable doses in their home setting.
- Technological Innovation in Injection Devices: Advanced biologic injectors, equipped with advanced smart technologies, wireless connectivity, and ease of use, improve patient compliance and treatment results. These innovations better control dosing, ensure minimal human error, and monitor patient adherence in real time. All this leads to market growth.
- Personalized Medicine and Self-Administration: Personalized medicine is increasing self-administration of biologic therapies. Biologic injectors, with their ergonomic designs, pre-filled syringes, and automatic injection systems, enable a patient-centric approach to convenient self-administered treatment, allowing a patient to give themselves appropriate medical treatment at home easily while maintaining better compliance.
- Digital Health Solutions: Biologic injectors are increasingly integrated with digital tools such as tracking injections via mobile apps, reminders for adherence, and remote monitoring. The technologies thus enable patients and healthcare providers to access real-time information, further enables patient management, optimizing therapeutic outcomes, and offers the healthcare system useful information that it can use for clinical decision-making.
- Technological Development and Standardization: For the sake of growth of the biologic injectors market, regulatory bodies strive for creating standardized norms in the matter of safety and efficacy of devices. A much stricter regulatory protocol would enforce manufacturers to ensure higher-quality safe and effective devices, increasing market confidence and faster product approval that fuels further expansion of the market.
- Improved Reimbursement in Emerging Markets: Asia-Pacific and Latin America are the regions where opportunities exist for biologic injectors, given developing regions. The rise in demand for efficient drug delivery is expected to grow as the diagnosed cases of chronic diseases increase. Improved reimbursement policies for biologics is likely to open up opportunities for key manufacturers in emerging economies.
- Government intervention: Rising participation by government authoroties in establishing standard practises in pharmaceuticals drug delivery and in setting up pricing framework of high-end biologic drugs is likely to open up room of opportunities for domestic manufacturers. This mainly applies to chronic disease management where improving patients' outcomes is one of the key factors taken into consideration by public players and drug regulatory authoroties.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Biologic Injectors Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Biologic Injectors Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The biologic injector market is estimated to grow with a CAGR of 10.3% from 2023 to 2031
The biologic injector market majorly consists of players such AbbVie, Amgen, BD among others
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period.
Self-administration of biologic therapies is likely to remain the key trend during the forecast period.
The market drivers include growing incidence of chronic conditions like diabetes, rheumatoid arthritis, and cancer and biotechnology and expansion of biologic drug therapies, such as monoclonal antibodies and gene therapies are driving the biologic injector market
North America dominated the biologic injector market in 2023
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biologic Injectors Market - By Application
1.3.2 Biologic Injectors Market - By End-User
1.3.3 Biologic Injectors Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOLOGIC INJECTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOLOGIC INJECTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOLOGIC INJECTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOLOGIC INJECTORS - GLOBAL MARKET OVERVIEW
6.2. BIOLOGIC INJECTORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOLOGIC INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. ONCOLOGY
7.3.1. Overview
7.3.2. Oncology Market Forecast and Analysis
7.4. CARDIOLOGY
7.4.1. Overview
7.4.2. Cardiology Market Forecast and Analysis
7.5. AUTOIMMUNE
7.5.1. Overview
7.5.2. Autoimmune Market Forecast and Analysis
7.6. PAIN MANAGEMENT
7.6.1. Overview
7.6.2. Pain management Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. BIOLOGIC INJECTORS MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. DRUG STORES
8.5.1. Overview
8.5.2. Drug Stores Market Forecast and Analysis
8.6. OTHER
8.6.1. Overview
8.6.2. other Market Forecast and Analysis
9. BIOLOGIC INJECTORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biologic Injectors Market Overview
9.1.2 North America Biologic Injectors Market Forecasts and Analysis
9.1.3 North America Biologic Injectors Market Forecasts and Analysis - By Application
9.1.4 North America Biologic Injectors Market Forecasts and Analysis - By End-User
9.1.5 North America Biologic Injectors Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biologic Injectors Market
9.1.5.1.1 United States Biologic Injectors Market by Application
9.1.5.1.2 United States Biologic Injectors Market by End-User
9.1.5.2 Canada Biologic Injectors Market
9.1.5.2.1 Canada Biologic Injectors Market by Application
9.1.5.2.2 Canada Biologic Injectors Market by End-User
9.1.5.3 Mexico Biologic Injectors Market
9.1.5.3.1 Mexico Biologic Injectors Market by Application
9.1.5.3.2 Mexico Biologic Injectors Market by End-User
9.2. EUROPE
9.2.1 Europe Biologic Injectors Market Overview
9.2.2 Europe Biologic Injectors Market Forecasts and Analysis
9.2.3 Europe Biologic Injectors Market Forecasts and Analysis - By Application
9.2.4 Europe Biologic Injectors Market Forecasts and Analysis - By End-User
9.2.5 Europe Biologic Injectors Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biologic Injectors Market
9.2.5.1.1 Germany Biologic Injectors Market by Application
9.2.5.1.2 Germany Biologic Injectors Market by End-User
9.2.5.2 France Biologic Injectors Market
9.2.5.2.1 France Biologic Injectors Market by Application
9.2.5.2.2 France Biologic Injectors Market by End-User
9.2.5.3 Italy Biologic Injectors Market
9.2.5.3.1 Italy Biologic Injectors Market by Application
9.2.5.3.2 Italy Biologic Injectors Market by End-User
9.2.5.4 Spain Biologic Injectors Market
9.2.5.4.1 Spain Biologic Injectors Market by Application
9.2.5.4.2 Spain Biologic Injectors Market by End-User
9.2.5.5 United Kingdom Biologic Injectors Market
9.2.5.5.1 United Kingdom Biologic Injectors Market by Application
9.2.5.5.2 United Kingdom Biologic Injectors Market by End-User
9.2.5.6 Rest of Europe Biologic Injectors Market
9.2.5.6.1 Rest of Europe Biologic Injectors Market by Application
9.2.5.6.2 Rest of Europe Biologic Injectors Market by End-User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biologic Injectors Market Overview
9.3.2 Asia-Pacific Biologic Injectors Market Forecasts and Analysis
9.3.3 Asia-Pacific Biologic Injectors Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Biologic Injectors Market Forecasts and Analysis - By End-User
9.3.5 Asia-Pacific Biologic Injectors Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biologic Injectors Market
9.3.5.1.1 Australia Biologic Injectors Market by Application
9.3.5.1.2 Australia Biologic Injectors Market by End-User
9.3.5.2 China Biologic Injectors Market
9.3.5.2.1 China Biologic Injectors Market by Application
9.3.5.2.2 China Biologic Injectors Market by End-User
9.3.5.3 India Biologic Injectors Market
9.3.5.3.1 India Biologic Injectors Market by Application
9.3.5.3.2 India Biologic Injectors Market by End-User
9.3.5.4 Japan Biologic Injectors Market
9.3.5.4.1 Japan Biologic Injectors Market by Application
9.3.5.4.2 Japan Biologic Injectors Market by End-User
9.3.5.5 South Korea Biologic Injectors Market
9.3.5.5.1 South Korea Biologic Injectors Market by Application
9.3.5.5.2 South Korea Biologic Injectors Market by End-User
9.3.5.6 Rest of Asia-Pacific Biologic Injectors Market
9.3.5.6.1 Rest of Asia-Pacific Biologic Injectors Market by Application
9.3.5.6.2 Rest of Asia-Pacific Biologic Injectors Market by End-User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biologic Injectors Market Overview
9.4.2 Middle East and Africa Biologic Injectors Market Forecasts and Analysis
9.4.3 Middle East and Africa Biologic Injectors Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Biologic Injectors Market Forecasts and Analysis - By End-User
9.4.5 Middle East and Africa Biologic Injectors Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biologic Injectors Market
9.4.5.1.1 South Africa Biologic Injectors Market by Application
9.4.5.1.2 South Africa Biologic Injectors Market by End-User
9.4.5.2 Saudi Arabia Biologic Injectors Market
9.4.5.2.1 Saudi Arabia Biologic Injectors Market by Application
9.4.5.2.2 Saudi Arabia Biologic Injectors Market by End-User
9.4.5.3 U.A.E Biologic Injectors Market
9.4.5.3.1 U.A.E Biologic Injectors Market by Application
9.4.5.3.2 U.A.E Biologic Injectors Market by End-User
9.4.5.4 Rest of Middle East and Africa Biologic Injectors Market
9.4.5.4.1 Rest of Middle East and Africa Biologic Injectors Market by Application
9.4.5.4.2 Rest of Middle East and Africa Biologic Injectors Market by End-User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biologic Injectors Market Overview
9.5.2 South and Central America Biologic Injectors Market Forecasts and Analysis
9.5.3 South and Central America Biologic Injectors Market Forecasts and Analysis - By Application
9.5.4 South and Central America Biologic Injectors Market Forecasts and Analysis - By End-User
9.5.5 South and Central America Biologic Injectors Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biologic Injectors Market
9.5.5.1.1 Brazil Biologic Injectors Market by Application
9.5.5.1.2 Brazil Biologic Injectors Market by End-User
9.5.5.2 Argentina Biologic Injectors Market
9.5.5.2.1 Argentina Biologic Injectors Market by Application
9.5.5.2.2 Argentina Biologic Injectors Market by End-User
9.5.5.3 Rest of South and Central America Biologic Injectors Market
9.5.5.3.1 Rest of South and Central America Biologic Injectors Market by Application
9.5.5.3.2 Rest of South and Central America Biologic Injectors Market by End-User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BIOLOGIC INJECTORS MARKET, KEY COMPANY PROFILES
11.1. ROCHE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ABBOTT
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SCHOTT
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. NIPRO
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. OMPI
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BECTON AND DICKINSON AND CO.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BAYER AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BRISTOL-MYER SQUIBB
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NOVARTIS INTERNATIONAL AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Roche
2. Abbott
3. Schott
4. Nipro
5. Ompi
6. Becton and Dickinson & Co.
7. Bayer AG
8. Pfizer, Inc.
9. Bristol-Myer Squibb
10. Novartis International AG
11. Samedan Ltd
12. E3D Elcam Drug Delivery Devices
13. Zealand Pharma A/S (Valeritas, Inc.)
14. Ypsomed AG,
15. Tandem Diabetes Care, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For